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We are in the midst of a dire, unprecedented, and global epidemic of obesity and secondary sequelae, most
prominently diabetes and hyperlipidemia. Underlying this epidemic is themost hated of cells, adipocytes, and
their inherent dynamic ability to expand and renew. This capacity highlights a heretofore undefined stem
compartment. Recent in vivo studies, relying upon lineage tracing and flow cytometry methods, have begun
to unravel the identity of adipose stem cells, their niche, and the dynamism central to adipose expansion.
Thus, the field is moving in a direction that may allow us to manipulate adipose stem cells to beneficial
therapeutic ends.Traditionally fueling strong emotions related to the aesthetics of
body image, adipocytes are now at the center of a medical-
sociological crisis that has changed the landscape of public
health. Indeed, obesity is central to the explosion of medical
costs that have triggered the national debate on health care
and is a major culprit behind the alarming fact that the life expec-
tancy of Americans is diminishing for the first time in generations
(Olshansky et al., 2005). Estimates indicate that obesity is
already responsible for >300,000 deaths each year in the United
States alone, triggering the largest growth in mortality over the
past decade (Allison et al., 1999). Moreover, the increase in
obesity and diabetes (a.k.a. ‘‘diabesity’’) is even greater in South-
east Asia, underscoring the global nature of this epidemic, with
estimates between 1.1 to 1.7 billion people affected (Hossain
et al., 2007).
Yet, there may be some shelter from this storm. Recent
insights into adipocyte biology—particularly the isolation of the
white adipose stem cell and identification of its niche—have
altered our understanding of adipose biology (Rodeheffer
et al., 2008; Tang et al., 2008). This work indicates that the
recruitment of stem cells into the adipose lineage is a regulated
process, one that occurs throughout life and may contribute to
the obesigenic phenotype. These find-
ings raise the possibility of unraveling the
mechanisms and molecules that control
these processes and the potential of
manipulating them to treat a variety of
serious medical conditions.
The Skinny on Fat: Location,
Location, Location
Adipose tissues regulate reproduction
and lifespan and provide thermal and
traumatic protection, but aremost notable
for their vital role in metabolism (Gregoire
et al., 1998; MacDougald and Mandrup,
2002; Spiegelman and Flier, 2001). In
contrast to the traditional view of adipocytes as a passive
storage site, adipose tissues are the largest endocrine organ,
actively controlling metabolism by secreting lipids, hormones,
and other factors (Nawrocki and Scherer, 2004; Waki and Tonto-
noz, 2007). The disease states—insulin resistance, hyperlipid-
emia, cardiovascular disease, diabetes, etc.—that accompany
both excess (obesity) and deficient (lipodystrophy) fat stores
highlight the central role of adipose tissues.
Adipocytes are of two broad functional and histological line-
ages: brown adipose tissues (BAT), which dissipate energy,
and white adipose tissues (WAT), which store energy (Figure 1)
(Gregoire et al., 1998;MacDougald andMandrup, 2002; Spiegel-
man and Flier, 2001). Brown adipocytes are primarily thermo-
genic, converting nutrients into heat. Thermogenesis is accom-
plished through the abundant number of mitochondria in BAT
(which are responsible for its signature brown color) and the
expression of uncoupling protein 1 (UCP-1), which uncouples
the proton electrochemical gradient from the generation of
ATP (Cannon and Nedergaard, 2004). Although relatively scarce
in adult humans, BAT may be more prevalent than previously
appreciated, and its ability to burn calories may enable it to be
manipulated for novel antiobesity strategies (Cypess et al.,
2009; van Marken Lichtenbelt et al., 2009;
Virtanen et al., 2009). For example, stimuli
such as cold exposure and b3 adrenergic
drugs stimulate the formation of brown
adipocytes within white adipose depots;
it is unclear whether these nascent brown
adipocytes somehow derive from white
adipocytes, from white adipose stem
cells, or from an as yet unidentified brown
adipose stemcell (Granneman andWhitty,
1991; Loncar et al., 1988; Rohlfs et al.,
1995). BMP7 may also play a related role
in regulating the BAT compartment (Tseng
et al., 2008). Studies indicate that during
murine development, at least some BAT
“eat ye that which is good 
and let your soul 
delight itself in fatness.”
Isaiah 55:2, ~750 BCE
“Our people are
killing themselves
with a fork.”
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Seale et al., 2008). Yet this does not appear to be the case during
the formation of BAT that, under the influence of external stimuli,
is inducedwithinWAT tissue (Seale et al., 2008). Therefore, itmay
ultimately be possible to reduce obesity anddiabetes by convert-
ing WAT, or the newly identified white adipose stem cells (see
below), to BAT (Elabd et al., 2009; Orci et al., 2004).
White adipocytes comprise the vast majority of adipocytes. In
times of caloric abundance, these cells store excess calories as
triglycerides, and in times of caloric need, release fuel (as fatty
acids and glycerol) for use by other organs. WAT is itself sub-
divided into subcutaneous and visceral (intra-abdominal) depots
(Figure 1). Importantly, visceral depots are much more strongly
associated with metabolic complications—markedly increas-
ing the risk of hyperlipidemia, diabetes and cardiovascular
disease—while subcutaneous beds appear protective against
these sequelae (Gesta et al., 2007; Shi and Clegg, 2009). Paral-
leling these distinctions, the two types of WAT, defined only by
location, also differ in morphology and function (Gesta et al.,
2006; Tchernof et al., 2006; Tchkonia et al., 2007). The mecha-
nisms and developmental cues that account for these unique
Figure 1. The Skinny on Fat: Location, Location, Location
In ancient times, the ability to become fat was associated with health, wealth,
and good fortune, but modern lifestyles have led to an unprecedented
medical-sociological-financial crisis, with obesity at epidemic proportions.
This is due to expansion of white adipose tissues (WAT), but there is also
brown adipose tissue (BAT) lineage. White adipose tissues are primarily
distributed subcutaneously (pear or female pattern), fat that appears to be
metabolically protective, or intra-abdomimably (apple or male pattern), fat that
is associated with enormous health risks. Adipose depots are remarkably
plastic, and recent evidence indicates that new fat cells derive from a stem
cell source (depicted as a stork in bottom outside panels).characteristics are unknown, however, and work in this area
has been hindered by a lack of reagents to enable researchers
to track and manipulate the different lineages in vivo.
Sex steroids are the best-characterized endogenous stimuli
that differentially affect the development, distribution and func-
tion of subcutaneous and visceral WAT depots (Shi and Clegg,
2009). Although men, on average, have less total body fat, they
have more visceral adipose tissue, whereas women have more
total and subcutaneous adipose tissue (Grauer et al., 1984).
The ‘‘female’’ or ‘‘pear’’ pattern of fat distribution develops
during puberty in an estrogen-dependent manner (de Ridder
et al., 1990). Further, estrogen treatment of males increases
subcutaneous adipose accrual relative to visceral adipose tissue
(Elbers et al., 1999). After menopause, as estrogen levels de-
cline, women develop increased visceral adiposity; however,
those who receive estrogen replacement therapy do not (Gam-
bacciani et al., 1997; Munoz et al., 2002). Therefore, gonadal
or ‘‘sex’’ steroids are endogenous regulators of fat distribution,
potentially through mechanisms involving adipose progenitors.
Indeed, the many differences between WAT depots may be
intrinsic to the depots and the stem cells located therein: indirect
evidence indicates that subcutaneous depots contain a greater
number of adipose progenitors, and these cells have a higher
proliferative and adipogenic potential than those located intra-
abdominally (Gesta et al., 2007; Joe et al., 2009; Tran et al.,
2008). This enhanced ability to generate adipocytes may be
protective against metabolic dysfunction, while the hypertrophic
response characteristic of visceral depots may be maladaptive
(Joe et al., 2009).
Adipose tissues are highly dynamic, expanding and shrinking
in response to various homeostatic, pharmacologic, and dietary
stimuli (Figure 1) (Gesta et al., 2007; Shi and Clegg, 2009; Spald-
ing et al., 2008; Spiegelman and Flier, 2001). This growth pattern
is due to both adipocyte hypertrophy and hyperplasia, the latter
highlighting the potential presence of a stem compartment
(Hirsch and Batchelor, 1976; Salans et al., 1973). As early as
the 1950s, there was evidence stemming from radio-labeled
nucleotides administered to rodents that brown and white
adipocytes have a defined lifespan, renew, and that adipose
tissues contain proliferative and label-retaining cells, presaging
current molecular analyses of stem compartments (Hellman
and Hellerstrom, 1961; Hollenberg and Vost, 1969). Human
radioactive labeling studies performed in the wake of increased
atmospheric nuclear emissions during the middle part of the
20th century showed that human adipocytes also turn over
continuously and at a rate much greater than previously believed
(Spalding et al., 2008). These observations suggested the exis-
tence of an adipogenic stem cell, and the behavior of adipose
tissue in pathological conditions further supported this possi-
bility. For example, adipose tissues regenerate following lipec-
tomy or liposuction, and adipose tissue is hyperplastic in obese
subjects (Mauer et al., 2001). In fact, adipocyte number can
increase during obesity formation, despite the higher rate of
apoptotic death in this setting (Strissel et al., 2007). Even in the
lean state, formation of new adipocytes appears to be a lifelong
regulated process. Despite this wealth of indirect evidence,
however, no direct proof in vivo of a physiologically relevant adi-
pogenic stem cell existed prior to recent studies highlighted
below.Cell Stem Cell 5, November 6, 2009 ª2009 Elsevier Inc. 473
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Move to the Head of the Class
Until recently, the majority of studies on adipocyte precursors
and adipogenic differentiation had been performed in vitro and
primarily using cultured cell lines (MacDougald and Mandrup,
2002). While this work provided valuable clues and insights,
most notably unraveling the adipogenic transcription cascade,
such in vitro studies do not allow the examination of many devel-
opmental questions that are vital to understand if we are to have
a clear picture of adipocyte biology. For example, the lack of
in vivo lineage analyses and stem cell marker delineation had,
until now, hindered identification of the adipose stem cell and
the characteristics of its niche, thereby precluding an under-
standing of how developmental, physiological, and pharmaco-
logical stimuli regulate the growth of adipose tissue.
Recent papers from Friedman’s group (Rodeheffer et al.,
2008) and our group (Tang et al., 2008) shed light on the molec-
ular signature of white adipose stem cells and the niche from
which they derive (Figure 2). The reports use cell surfacemarkers
or lineage tracing to identify and prospectively isolate the stem
cells and to demonstrate the ability of these newly identified cells
to self-renew and, following transplantation, to form functional
adipose depots. Moreover, these in vivo studies show that white
adipose stem cells reside within the mural cell compartment of
blood vessels that supply adipose depots (Figure 2). These
papers employ a range of new in vivo tools and novel methodol-
ogies to confirm long-suspected but unproven notions about
adipose stem cells.
Two important features help define stem cells: self-renewal
and differentiation into cells of the tissues in which they reside.
For example, neural stem cells reside within neural tissue,
muscle stem cells reside within muscle, and breast stem cells
reside within the breast. Lineage studies reveal that these
tissue-resident stem cells are not pluripotent but rather differen-
tiate into a limited set of cell types. While these cells are critical
for normal tissue biology, finding the needle (e.g., stem cell) in
the proverbial haystack (e.g., tissue of interest) is often a signifi-
cant challenge. Onewidely implemented strategy is to dissociate
the relevant tissue, sort the cells based on cell-surface markers
using fluorescence-activated cell sorting (FACS), and then to
functionally test the isolated fractions in cell culture and after
transplantation (Morrison et al., 1999; Shackleton et al., 2006;
Spangrude et al., 1988; Stingl et al., 2006). An advantage of
this methodology is that related or overlapping sets of the iden-
tified cell-surface markers may also be present on the analogous
human stem cell population. What’s more, the identified cell
surface markers are easily communicated to, and disseminated
within, thescientificcommunitywhere theycanbe rapidlyapplied
in a variety of experimental settings. A drawback of such tech-
niques, however, is that they can alter cellular phenotype and
that they disrupt the normal tissue architecture and, therefore,
place cells in proximitywith nonphysiological neighbors (Javazon
et al., 2004). Moreover, while flow cytometry studies can enrich
for stem cells, the sorted samples are typically heterogeneous.
Nevertheless, such studies have been quite influential and suc-
ceeded in defining several stem cell populations: notable exam-
ples include hematopoeitic stem cells, neural stem cells, and
breast epithelial stem cells (Morrison et al., 1999; Shackleton
et al., 2006; Spangrude et al., 1988; Stingl et al., 2006).474 Cell Stem Cell 5, November 6, 2009 ª2009 Elsevier Inc.Tissue dissociation studies implicated the adipose stromal-
vascular (SV) compartment as the site of origin of adipose
stem cells (Hollenberg and Vost, 1969; Rodeheffer et al., 2008;
Tang et al., 2008). The SV fraction is operationally defined as
the heterogeneous mixture of cells that is isolated by enzymatic
dissociation and density separation, a procedure designed to
remove the assortment of cells that reside in the depot from
surrounding adipocytes, which float. These SV cells are a poten-
tially rich resource to examine a variety of questions relevant to
adipogenesis, as well as to regenerative medicine. For within
this complex set of cells are adipose-derived stem cells (ADSCs),
and also strikingly similar mesenchymal stem cells (MSCs), that
can be induced into a variety of cell types, including bone, carti-
lage, fat, muscle, and perhaps even endothelial cells and
neurons (Crisan et al., 2008; Planat-Benard et al., 2004; Yama-
moto et al., 2007; Zuk et al., 2002). Of note, the identity and
lineage of both ADSCs and MSCs is controversial (Bianco
et al., 2008). Nonetheless, while possibly a subset of the afore-
mentioned ADSCs and MSCs populations, the SV fraction also
contains bona fide adipose stem cells, possibly a subset of the
aforementioned ADSC and MSC populations. When such cells
are isolated from BAT, they form brown-like adipocytes that
express UCP-1 (Tseng et al., 2008), while those isolated from
Figure 2. Adipose Stem Cells Reside in a Vascular Niche
White adipose stem cells, marked green, reside in a vascular niche embedded
within the wall of blood vessels that supply fat tissues. This location is well
suited to receive environmental stimuli such as nutritional cues, indicated by
a supersized soda, that can trigger the cells to leave their niche and mature
into fat cells.
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tics (Rodeheffer et al., 2008; Tang et al., 2008). The SV compart-
ment has therefore attracted a great deal of attention, and there
have been several attempts, using both rodent and human
adipose tissues, to identify relevant markers to distinguish the
cell types in this microenvironment (Gronthos et al., 2001; Yosh-
imura et al., 2006; Zannettino et al., 2008). In that regard, the cell-
surface markers Sca-1 and CD-34 provided some refinement to
this complex mixture.
The work of Rodeheffer and colleagues significantly advanced
the ability to isolate cells of interest from the SV fraction. They
employed an elegant FACS-based protocol to isolate a subpop-
ulation of cells able to generate adipocytes following transplan-
tation into, and restore adipose function to, a lipodystrophic
mouse model that has a markedly reduced amount of adipose
tissue (Rodeheffer et al., 2008). They reasoned that the lack of
adipose tissue in these mice would lead to a strong endogenous
adipogenic stimulus. As a donor, Rodeheffer and colleagues
exploited a mouse strain that selectively expresses luciferase,
driven by a leptin bacterial artificial chromosome, in mature
adipocytes. This approach allowed them to visualize adipose
development in a noninvasive manner by imaging luciferase
activity in live animals. Notably, although several of the different
FACS-isolated subpopulations had multilineage and adipogenic
potential in vitro, only one fraction—Lin, CD29+, CD34+, Sca1+,
CD24+—formed adipose depots after transplantation into the ill-
formed perigonadal depots of lipodystrophic mice. Two weeks
after the procedure, luciferase expression was observed at the
transplant site. And, these incipient adipose depots approxi-
mated the size of wild-type depots twelve weeks following trans-
plant. This newly formed depot corrected hyperinsulinemia and
hyperglycemia (e.g., diabetes), two metabolic hallmarks of
lipodystrophy. More than 50% of AIDS patients on anti-HIV
medications suffer from lipodystrophy as a side effect, under-
scoring the prevalence of this syndrome and the potential thera-
peutic implications of this finding (Grinspoon and Carr, 2005).
Using a different experimental strategy, our group indepen-
dently identified white adipose stem cells expressing roughly
the same set of cell-surface proteins (Tang et al., 2008). Lineage
analysis, a powerful experimental strategy in which the introduc-
tion of molecular markers into progenitor populations allows for
the delineation of stem cell behavior in vivo, was used in this
study. For over a century, lineage studies have been used to
define the fate of a field of progenitors or stem cells (Stern and
Fraser, 2001). Indeed, lineage studies have been instrumental
in a vast number of important advances in developmental bio-
logy, spanning the discovery of neural induction in Spemann’s
era to current studies unraveling the generation of neuronal
diversity (Graff, 1997; Livet et al., 2007; Stern and Fraser,
2001). Lineage studies have historically involved several basic
strategies. In one, classically employed in amphibian embryos,
developing cells are labeled with vital dyes that are used to track
cells over time and space. Direct observation, based upon
pigmentation or morphology, has also been exploited; poten-
tially the pinnacle of these studies was the nearly complete defi-
nition of the C. elegans lineage. A related approach involved the
transplantation of donor tissues or cells into host organisms,
often generating interspecies chimeras, with the transplanted
cells being discriminated from host tissues microscopically(e.g., by cell size), by heterochromatin structure, or by altered
pigmentation (Stern and Fraser, 2001). Unfortunately, many of
these approaches are restricted in mammals because in utero
development prevents precise spatial and temporal localization,
for example, of the transplants. To overcome these limitations,
scientists employed viral marking or, more recently, markers
that are engineered into the mouse genome (Cepko et al.,
2000; Gu et al., 2002; Tang et al., 2008). Such modern genetic
lineage tracing has provided tremendous insight for pancreas
development, neural stem cells, muscle stem cells, and epi-
dermal stem cells (Gu et al., 2002; Horsley et al., 2006; Lepper
et al., 2009; Livet et al., 2007).
The lineage tracing experiments that led to the identification of
the adipose stem cell relied upon an extensive series of previous
studies that had unraveled the molecular underpinnings of adi-
pogenesis. ‘‘Adipogenesis’’ refers to the differentiation of cul-
tured preadipocytes into mature adipocytes. The most widely
used model of adipogenesis is the in vitro differentiation of the
3T3-L1 ‘‘preadipocyte’’ cell line. This system was used to char-
acterize an important adipogenic transcriptional hierarchy
involving C/EBPs, SREBP, and PPARg (Gregoire et al., 1998;
MacDougald and Mandrup, 2002; Spiegelman and Flier, 2001),
and microRNAs have more recently been implicated in this
pathway (Sun et al., 2009; Wang et al., 2008). PPARg, a nuclear
hormone receptor, is a central regulator of fat biology (Gregoire
et al., 1998; MacDougald and Mandrup, 2002; Spiegelman and
Flier, 2001). It is expressed in the adipose anlagen by embryonic
day 13.5, long before adipocytes are formed (Kliewer et al.,
1994). PPARg is necessary and sufficient for adipogenesis
in vitro, and the necessity almost certainly translates for fat
formation in vivo as well (Gregoire et al., 1998; MacDougald
and Mandrup, 2002; Spiegelman and Flier, 2001). Conventional
homozygous mutants lacking PPARg die early in utero,
precluding characterization of adipose formation in the null
mutants, but a variety of further studies–– tetraploid rescues,
chimeric analyses, mutant ESC, and mutant MEF studies, as
well as conditional and hypomorphic alleles––all point to a
requirement for PPARg in fat development (Barak et al., 1999;
Duan et al., 2007; Koutnikova et al., 2003; Kubota et al., 1999;
Rosen et al., 1999). It is also worth noting that PPARg is
expressed at low levels within the aforementioned SV fraction,
the very compartment that contains adipose stem cells (Tonto-
noz and Spiegelman, 2008).
Based upon this work, lineage analyses were performed on
mice in which PPARg-expressing cells were marked (Tang
et al., 2008). These studies relied upon mice in which the doxy-
cycline (Dox) repressible transcription factor tTA (‘‘Tet-off’’)
was placed under control of the PPARg locus, and these mice
were crossed to two lines that express different markers in
a tTA-dependent fashion: one that expresses an indelible lacZ
reporter and one that expresses a proliferation-sensitive GFP
reporter. The mice resulting from these crosses were used in
combination with BrdU-labeling strategies to examine adipose
stem cell behavior. Using this ‘‘Adipo-Trak’’ system, we found
that PPARg-expressing cells display the properties expected
of adipose stem cells. These cells are present prior to birth and
behave as an amplifying and self-replenishing population that
contributes to the adipocytes present in the white adipocyte
lineage. Moreover, this same population was stronglyCell Stem Cell 5, November 6, 2009 ª2009 Elsevier Inc. 475
Cell Stem Cell
Reviewadipogenic in vitro and formed ectopic adipose depots even
after transplantation into wild-type mice. Molecular, expres-
sion-profiling, and FACS studies were used to further elucidate
themolecular characteristics of these cells, andmany of the find-
ings are similar to those of Rodeheffer and colleagues.
A Bloody Niche
Stem cells reside in a specialized environment, a niche, that
controls many aspects of their behavior—quiescence, prolifera-
tion, and differentiation (Jones and Wagers, 2008; Li and Xie,
2005). Therefore, niche identification and characterization are
significant and dynamic areas of stem cell biology with many
recent revelations. Immunohistochemical methods, combined
with GFP marking, showed that adipose stem cells are found
in the wall of blood vessels that supply white adipose depots
but are absent from blood vessels that supply other tissues
(Tang et al., 2008). Utilizing the GFP marker, we characterized
a microanatomic location of adipocyte stem cells and demon-
strated that many coexpress three mural cell markers (SMA,
PDGFRb, and NG2), arguing that adipose stem cells constitute
a subset of mural cells embedded in the wall of blood vessels
present within adipose tissue (Figure 2). PDGFRb cell-surface
expression is characteristic of the mural population, comprised
of vascular smooth muscle cells and pericytes, and is required
for their formation (Jain, 2003). Notably, lineage tracing with a
PDGFRb-cre strain and cell sorting based upon PDGFRb
expression followed by in vitro or in vivo adipogenesis assays
were all consistent with the idea that a subset of mural cells
are indeed adipose stem cells.
The idea that the mural compartment is a reservoir for adipose
stem cells reverberated with studies done more than 25 years
ago involving fat depot transplantation and fat depot thermal
lesions (Iyama et al., 1979; Napolitano, 1963; Richardson et al.,
1982). These experiments indicated that an uncommon subset
of adipose depot resident cells were near endothelial cells,
possessed long cytoplasmic processes (pericyte-like attributes),
and contained multiple, small lipid droplets. The emerging
biology of ADSCs and MSCs provide indirect support for the
possibility that the adipose stem cell resides in the mural
compartment (Lin et al., 2008; Traktuev et al., 2008). Indeed,
pericytes in a variety of tissues have been proposed as an
MSC repository (Crisan et al., 2008). How the GFP marked cells
(Tang et al., 2008) relate to this pool is unknown, although it
seems plausible that they represent a subset of this population.
To further investigate a blood vessel niche of the adipose stem
cells, a procedure was developed to isolate the SV particulate
(SVP) (Tang et al., 2008). This method was designed to maintain
the native SV structure in which a niche is located while removing
adipocytes that obscure visualization of precursor location.
Analysis of these purified SVPs showed mural marker-express-
ing stem cells beautifully arrayed around vessels. The stem cells
present in freshly isolated SVP vessels did not contain lipid drop-
lets, whereas organotypic cultures of SVPs led to formation of
lipid-laden GFP+ adipocytes along the blood vessels, indicating
that the vessel-associated and lineage-marked stem cells were
indeed adipogenic. Thus, this ex vivo experimental system
preserves niche microanatomy and allows the assessment and
manipulation of stem cells within this critical and privileged
environment.476 Cell Stem Cell 5, November 6, 2009 ª2009 Elsevier Inc.It is also important to underscore that to be defined as a niche,
the microenvironment must provide regulatory inputs to the resi-
dent stem cell beyond simply representing a physical location.
And our studies have yet to establish this key requirement. But
the results discussed above do build upon a diverse series of
reports implicating the blood vessel as a potentially important
niche for a variety of progenitors, including hematopoietic and
neural stem cells, that appear to be in direct contact with blood
vessels (Hooper et al., 2009; Shen et al., 2008; Tang et al., 2008;
Tavazoie et al., 2008). The identification of the vasculature as an
adipose stem cell niche also supports earlier studies indicating
that adipocytes form in intimate juxtaposition with blood vessels
and that adipogenesis and angiogenesis are tightly orchestrated
(Crandall et al., 1997; Kolonin et al., 2004; Tang et al., 2008). For
example, the number of adipose stem cells present within a
depot correlates with vascular density. Light and electron micro-
scopic studies (some described above) performed as early
as the 1960s suggested that adipose stem cells reside in or
near the blood vessel. Some micrographs from these studies
created the impression that developing fat cells were pulling
away from, or even emerging from, the vasculature (Iyama
et al., 1979; Napolitano, 1963; Richardson et al., 1982). During
development, adipose depot vasculogenesis correlates tempo-
rally and spatially with adipocyte formation, and angiogenesis
similarly correlates with the expansion of the adipocyte compart-
ment observed in obesity (Cao, 2007; Crandall et al., 1997; Fuku-
mura et al., 2003; Neels et al., 2004).
Classical morphological studies suggest that an early event
in adipocyte development is the formation of a capillary network
in loose regions of mesenchymal or connective tissue. During
development, the appearance of vascular structures often
precedes slightly the formation of fat cells in the primitive fat
anlagen, after which adipocytes appear to sprout along the
vasculature (Iyama et al., 1979). Several studies indicate that
blood vessel development may promote recruitment of adipose
stem cells, may stimulate adipogenesis, and may induce the
morphogenic movements required to correctly localize adipo-
cytes (Cao, 2007; Crandall et al., 1997; Fukumura et al., 2003;
Neels et al., 2004). Notably, this relationship may reflect a recip-
rocal process as adipose lineage cells secrete a variety of angio-
genic regulators, including vascular endothelial growth factor
(VEGF), plasminogen activator inhibitor-1, fibroblast growth
factor 2, and many matrix metalloproteinases (Cao, 2007).
In vitro ‘‘mixing’’ studies aggregating adipose depot resident
stem cells with endothelial cells indicate that the stem cells stim-
ulate the ability of endothelial cells to form vessels (Traktuev
et al., 2009). Nishimura et al. observed so called ‘‘adipogenic/
angiogenic cell clusters’’ in which adipogenesis and angiogen-
esis occur in close proximity. Notably, these clusters increase
significantly in genetically obese db/db mice (Nishimura et al.,
2007), indicating that both compartments are stimulated to
expand in obesity (see ‘‘From Stem to Stern’’ below).
Since the vasculature may supply important cues for adipo-
cyte stem cells—controlling the balance between quiescence,
proliferation, and differentiation—antiangiogenic factors seem
a plausible approach for treating obesity. Indeed a spectrum of
angiogenic inhibitors reversibly reduced murine obesity,
although these studies suffer from possible confounds of an
anorexic effect (Rupnick et al., 2002). Kolonin and colleagues
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depot endothelium. They then developed a proapoptotic peptide
linked to this motif that, when administered to genetically obese
and diabetic ob/obmice, rapidly mitigated obesity and improved
metabolic profiles (Kolonin et al., 2004). Similarly, treating obese
db/db mice with an anti-VEGF antibody reduced adipose depot
size and diminished the number of small, apparently nascent,
adipocytes, as well as the aforementioned adipogenic/angio-
genic clusters (Nishimura et al., 2007). Thus, inhibiting angiogen-
esis in adipose tissues may prove effective in ameliorating
obesity and its sequelae.
From Stem to Stern: Stem Cells and the Obesigenic
Phenotype
Surplus caloric intake and limited energy expenditure are
common features of modern life and pose a great challenge for
metabolic homeostasis. In large part, adipose tissues provide
an evolutionarily programmed adaptation to this challenge,
sequestering fatty acids, toxic to most tissue, within adipocytes
(Gregoire et al., 1998;MacDougald andMandrup, 2002; Spiegel-
man and Flier, 2001). Adipose tissues have an extraordinary
ability to expand, perhaps more than any other tissue (Gesta
et al., 2007; Hossain et al., 2007; Olshansky et al., 2005; Spiegel-
man and Flier, 2001). In principal, this expansion could involve
several mechanisms with adipocyte hyperplasia and adipocyte
hypertrophy primarily considered. The relative contributions of
these two processes depend upon genetic factors, diet, and
the particular depot (inguinal, perigonadal, etc.) under investiga-
tion. The presence of a hyperplastic response indicates the
involvement of the stem cell compartment, but this interpretation
does not imply that stem cell recruitment is the driving force for
expansion. What is quite clear is that adipocyte hypertrophy is
common in the development of obesity; indeed, individual adipo-
cytes have a remarkable capacity to expand with estimates of
a 2- to 3-fold increased volume (Hirsch and Batchelor, 1976; Sal-
ans et al., 1973). Yet once the stimulus (e.g., caloric intake
greater than expenditure) is prolonged, the hypertrophic
response may contribute to metabolic dysregulation. Since
new adipocytes are thought protective against metabolic
dysfunction, it is plausible that these maladaptive responses
could be reversed by recruiting additional cells from a stem
compartment.
Following the identification of the Lin, CD29+, CD34+, Sca1+,
CD24+ adipose stem cells, Rodeheffer and colleagues also
probed the role of these cells in obesity and uncovered intriguing
clues (Rodeheffer et al., 2008). In this case, they transplanted the
Lin, CD29+, CD34+, Sca1+, CD24+ population derived from
adipocyte-luciferase mice into adipose depots of wild-type
mice, rather than those with a paucity of fat as described above.
However, no adipocyte formation was detected when the wild-
type recipients were fed a normal mouse diet (<10% fat). In
contrast, feeding the recipient mice a high-fat diet induced
formation of adipocytes, scored by expression of luciferase, indi-
cating that, similar to animals with lipodystrophy, obese animals
contain physiological (or pathophysiological) signals that stimu-
late adipose stem cells.
Weighing into the fray, Joe et al. studied a Lin, Sca1+, CD24+
population present in the adipose SV fraction in control and high-
fat diet conditions (Joe et al., 2009). Although this Lin, Sca1+,CD24+ contingent may be relatively heterogeneous, Joe and
colleagues hypothesized that aspects of biological responses
provoked therein might reflect the behavior of the included
adipose stem cell subpopulation. In support of this notion,
several studies report that isolated SV fraction cells display adi-
pogenic behavior in vitro similar to that observed in vivo (Scime
et al., 2005; Sengenes et al., 2005). Employing high-fat feeding,
BrdU labeling, and flow cytometry, Joe and colleagues observed
that the dietary stimulus increased proliferation of the Lin,
Sca1+, CD24+ fraction (Joe et al., 2009).
Additional lines of evidence support the idea that dietary cues
can recruit stem cells into the adipogenic lineage. Bone marrow
is a rich resource of a variety of stem cell populations, including
hematopoeitic stem cells and multipotent MSCs. Bone marrow
also contains adipocytes—and perhaps adipocyte stem cells—
and the number of marrow resident adipocytes increases with
age as well as in various pathophysiological conditions (e.g.,
osteoporosis). Crossno et al. transplanted labeled bone marrow
into unlabeled hosts and observed labeled cells with character-
istics of adipocytes, although these cells exhibited a multilocular
rather than a prototypical unilocular appearance, in host adipose
cells. Interestingly, this process was stimulated by high-fat diet
(Crossno et al., 2006). However, a closely related follow-up
report, albeit with some experimental distinctions, seems at
odds with these data (Koh et al., 2007). Thus, several lines of
evidence indicate that adipose stem cells play a role in obesity
formation and are regulated by diet and obesity. Future experi-
ments, for example, ablating adipose stem cells or altering their
biology with pharmacologic or genetic means, are now required
to rigorously assess their role in a variety of physiological and
disease-related settings.
Adipose Stem Cells: Potential Therapeutic Applications
The identification of adipose stem cells and the tools to analyze
them will enable investigators to explore and manipulate these
cells in a variety of clinically relevant situations (Figure 3).
Adipose tissue is an abundant source of stem cells (see below)
that can be used for various regenerative approaches, but
such methods have been reviewed in detail recently and will
therefore not be discussed here (Gurdon and Melton, 2008;
Hansson et al., 2009). The treatment of lipodystrophy, described
above, will require inducing the stem cells to form adipose tissue,
their natural path. Another promising application is the treatment
of women who have undergone lumpectomy for breast cancers.
Currently available reconstructive surgery using synthetic mate-
rials is often unsatisfactory, and moving fat depots, or mature
adipocytes, from other locations is currently untenable. Trans-
planted adipose stem cells may overcome the problems, as
they recruit a vascular supply and have a natural texture (Rode-
heffer et al., 2008; Tang et al., 2008; Yoshimura et al., 2008). This
strategy could also be used to correct other anatomical defects,
for example in reconstructive surgery following trauma, as well
as for wound healing, as adipose stem cells appear to stimulate
this process (Lu et al., 2008; Nambu et al., 2007). Related appli-
cations for adipose stem cells are also widely desired for
cosmetic purposes, and a large ‘‘body sculpting’’ industry is
dedicated to finding available sources (Matsumoto et al., 2006).
In essence, one could remove unwanted fat and then isolate and
transplant the stem cells into a desired location. Such anCell Stem Cell 5, November 6, 2009 ª2009 Elsevier Inc. 477
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Hollywood blockbuster.
In addition to reconstructive, regenerative, or reprogramming
applications, adipose stem cells might also be directed toward
the very diseases in which they are implicated. Subcutaneous
WAT can counteract or reduce metabolic dysfunction, so
isolating, expanding, and reimplanting subcutaneous adipose
stem cells might be used to reduce blood glucose, cholesterol
levels, and even cancer risk. The isolated stem cells might be
manipulated to enhance their capacity to produce subcutaneous
adipocytes or a heightened subcutaneous adipocyte signature,
perhaps by treating them with small molecules; estrogenic
signals are one potential avenue. An alternate strategy might
be to induce white adipose stem cells into a brown-like pheno-
type, enhancing energy dissipation following reimplantation.
Thermogenic (cold exposure), pharmacologic (b3 adrenergic
agonists, BMP7), or genetic (PDRM16) stimuli might be advanta-
geous in this regard (Cannon andNedergaard, 2004; Granneman
andWhitty, 1991; Seale et al., 2008; Tseng et al., 2008). The exis-
tence of an adipose stem cell niche in the blood vessel wall
suggests that they are well situated to receive blood-borne
cues or stimuli, such as small molecules or even gene therapy.
Regardless of the therapeutic application, adipose stem cells
should be relatively easy to obtain, as humans harbor a striking
amount of adipose tissue, which is a plentiful source of stem
cells. According to the Center for Disease Control, the average
American man or woman has more than 50 pounds of fat, and
even a lean woman is more than 15% adipose tissue (the current
Figure 3. Adipose Stem Cells Have Clinical Promise
Adipose stem cells have a variety of clinical applications: reconstructive appli-
cations, protective transformations, and therapeutic applications. Recon-
structive applications broadly encompass surgical, genetic or traumatic
defects as well as purely cosmetic purposes. Protective transformations
denote induction of a heightened subcutaneous, metabolically protective,
adipose signature (pear fat), preferentially over a visceral one (apple fat); this
latter type is strongly associated with disease risk. These protections, which
do not reduce total fat mass, either change the phenotype of extant depots
or change where the fat is located, diverting fat storage to subcutaneous
depots. Therapeutic refers to molding the white, energy storing, adipose
lineage to a brown-like, energy burning, adipocyte fate, thereby reducing
obesity and metabolic dysfunction. These approaches exploit the proclivity
of adipose lineage cells to form adipocytes, a feature that paradoxically may
be exploited to cure obesity and diabetes.478 Cell Stem Cell 5, November 6, 2009 ª2009 Elsevier Inc.average range for an American woman is 32%–42%). Thus, at
120 pounds (picture an Olympian), a woman may harbor more
than a dozen pounds of fat from which to procure stem cells.
On the other end of the spectrum, an obese man (current
average range for American men is 23%–31% body fat) may
contain hundreds of pounds of adipose tissue. What’s more,
plastic surgeons routinely perform liposuction, removing and
discarding unwanted fat along with the embedded stem cells.
Thus the procedures for adipose stem cell isolation are already
well established, minimally invasive, and safe.
Future Basic Science Directions
The insights and tools provided by the reports reviewed above
will now enable investigators to address a variety of fundamental
questions; the answers to many have important therapeutic
implications. Do adipose stem cells arise in situ in the vessel,
or do they form elsewhere and migrate to the vessel wall?
What are the niche-derived signals that control adipose stem
cell biology and how might we harness the signals for desired
therapeutic outcomes? Are the white adipose stem cells impor-
tant in homeostasis andmaintenance or just in response to high-
fat diet? Since the stem cells appear to inhabit a therapeutically
accessible niche, do current treatments for diabetes, for
example, thiazolidinediones that activate the stem cells in vitro,
alter their biology in vivo? Although we are in the midst of a
dire and intertwined epidemic of diabesity, the answers to these
questions and the recently described discoveries provide
a hopeful light within this roiling tempest.
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